1. The role of metabolic reprogramming in pancreatic cancer chemoresistance
   Chang Liu et al, 2023, Frontiers in Pharmacology CrossRef
2. Recent Update and Drug Target in Molecular and Pharmacological Insights into Autophagy Modulation in Cancer Treatment and Future Progress
   Md. Ataur Rahman et al, 2023, Cells CrossRef
3. A bioinformatics analysis, pre-clinical and clinical conception of autophagy in pancreatic cancer: Complexity and simplicity in crosstalk
   Milad Ashrafizadeh et al, 2023, Pharmacological Research CrossRef
4. Phyllanthus emblica L. extract alleviates leptin resistance and lipid accumulation by inhibiting methylglyoxal production
   Yue-Ning Huang et al, 2023, Food Bioscience CrossRef
5. THE INFLUENCE OF SOME MEDICINAL MUSHROOMS USED IN ETHNIC MEDICINE ON MALIGNANT CELLS.
   I.G. Strokina et al, 2024, Medical Science of Ukraine (MSU) CrossRef
6. Acquired and intrinsic gemcitabine resistance in pancreatic cancer therapy: Environmental factors, molecular profile and drug/nanotherapeutic approaches
   Milad Ashrafizadeh et al, 2024, Environmental Research CrossRef
7. Heme Oxygenase-1 Inhibition Modulates Autophagy and Augments Arsenic Trioxide Cytotoxicity in Pancreatic Cancer Cells
   Iman M. Ahmad et al, 2023, Biomedicines CrossRef
8. CircLMTK2 Silencing Attenuates Gemcitabine Resistance in Pancreatic Cancer by Sponging miR-485-5p and to Target PAK1
   Yeting Lu et al, 2022, Journal of Oncology CrossRef
9. MAT as a promising therapeutic strategy against triple-negative breast cancer via inhibiting PI3K/AKT pathway
   Shijie Wei et al, 2023, Scientific Reports CrossRef